GLS2 and cancer: The percentage of cancers in which a GLNM regulator had an effect on a certain pathway showed that the transporters, including SLC7A5, SLC7A11, SLC3A2, and SLC1A5, were involved in the activation of apoptosis and the cell cycle in most cancer types, while GLS2 was mainly involved in the activation of hormone AR and GLS was mainly involved in the activation of EMT (Figure 9B).